Terms: = Lymphoma AND PAX5, Q02548, 5079, ENSG00000196092, BSAP AND Treatment
144 results:
1. Primary cutaneous anaplastic large-cell lymphoma resembling infratemporal space infection: a case report.
Yan X; Ren W; Li S; Zhu Z; Gao L; Zhi K
BMC Oral Health; 2024 Apr; 24(1):470. PubMed ID: 38637781
[TBL] [Abstract] [Full Text] [Related]
2. Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations.
van Outersterp I; Boer JM; van de Ven C; Reichert CEJ; Boeree A; Kruisinga B; de Groot-Kruseman HA; Escherich G; Sijs-Szabo A; Rijneveld AW; den Boer ML
Blood Adv; 2024 Apr; 8(8):1835-1845. PubMed ID: 38386975
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic significance of programmed cell death protein 1 and its ligand on lymphoma cells and tumor-immune cells in diffuse large B-cell lymphoma, not otherwise specified.
Slak TC; Miceska S; Gasljevic G; Boltezar L; Kloboves-Prevodnik V
Radiol Oncol; 2024 Mar; 58(1):99-109. PubMed ID: 38378036
[TBL] [Abstract] [Full Text] [Related]
4. Combination of minimal residual disease on day 15 and copy number alterations results in BCR-ABL1-negative pediatric B-ALL: A powerful tool for prediction of induction failure.
Baghdadi H; Soleimani M; Zavvar M; Bahoush G; Poopak B
Cancer Genet; 2024 Apr; 282-283():27-34. PubMed ID: 38183785
[TBL] [Abstract] [Full Text] [Related]
5. A rare case of fluid overload-associated large B-cell lymphoma and antigen loss at relapse.
Yan X; Chen B; Jing H; Yang Z; Zhang T; Lin Y; Shi J
J Hematop; 2023 Dec; 16(4):235-240. PubMed ID: 38175437
[TBL] [Abstract] [Full Text] [Related]
6. Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL.
Bastian L; Beder T; Barz MJ; Bendig S; Bartsch L; Walter W; Wolgast N; Brändl B; Rohrandt C; Hansen BT; Hartmann AM; Iben K; Das Gupta D; Denker M; Zimmermann J; Wittig M; Chitadze G; Neumann M; Schneller F; Fiedler W; Steffen B; Stelljes M; Faul C; Schwartz S; Müller FJ; Cario G; Harder L; Haferlach C; Pfeifer H; Gökbuget N; Brüggemann M; Baldus CD
Blood; 2024 Apr; 143(14):1391-1398. PubMed ID: 38153913
[TBL] [Abstract] [Full Text] [Related]
7. High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia.
Oikonomou A; Valsecchi L; Quadri M; Watrin T; Scharov K; Procopio S; Tu JW; Vogt M; Savino AM; Silvestri D; Valsecchi MG; Biondi A; Borkhardt A; Bhatia S; Cazzaniga G; Fazio G; Bardini M; Palmi C
Biochem Pharmacol; 2023 Nov; 217():115809. PubMed ID: 37717691
[TBL] [Abstract] [Full Text] [Related]
8. lymphomas of Central Nervous System.
Yokogami K; Azuma M; Takeshima H; Hirai T
Adv Exp Med Biol; 2023; 1405():527-543. PubMed ID: 37452952
[TBL] [Abstract] [Full Text] [Related]
9. EBV-Positive Intravascular Large B-Cell lymphoma of the Small Intestine: A Case Report and Literature Review.
Pan C; Ma X; Yao Y; Wang C
Int J Surg Pathol; 2024 May; 32(3):586-593. PubMed ID: 37431259
[TBL] [Abstract] [Full Text] [Related]
10. Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
Correia C; Maurer MJ; McDonough SJ; Schneider PA; Ross PE; Novak AJ; Feldman AL; Cerhan JR; Slager SL; Witzig TE; Eckloff BW; Li H; Nowakowski GS; Kaufmann SH
Blood Cancer J; 2023 May; 13(1):81. PubMed ID: 37193683
[TBL] [Abstract] [Full Text] [Related]
11. BET inhibition targets ABC-DLBCL constitutive B-cell receptor signaling through pax5.
Oien DB; Sharma S; Hattersley MM; DuPont M; Criscione SW; Prickett L; Goeppert AU; Drew L; Yao Y; Zhang J; Chan HM
Blood Adv; 2023 Sep; 7(17):5108-5121. PubMed ID: 37184294
[TBL] [Abstract] [Full Text] [Related]
12. Optical Genome Mapping Reveals and Characterizes Recurrent Aberrations and New Fusion Genes in Adult ALL.
Vieler LM; Nilius-Eliliwi V; Schroers R; Vangala DB; Nguyen HP; Gerding WM
Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980958
[TBL] [Abstract] [Full Text] [Related]
13. Clinicopathologic characteristics, genetic features, and treatment options for acute lymphoblastic leukemia with JAK2 rearrangement-A 10-case study and literature review.
Zhang L; Shah B; Zhang Y; Tashkandi H; Xiao W; Fernandez-Pol S; Vergara-Lluri M; Hussaini M; Song J; Lancet J; Moscinski L; Yun S; Lu CM; Medeiros LJ; Tang G
Hum Pathol; 2023 Jun; 136():1-15. PubMed ID: 36958463
[TBL] [Abstract] [Full Text] [Related]
14. Secondary involvement of gallbladder by acute lymphoblastic leukemia presenting clinically as cholecystitis in a young patient: a case report.
Rahim S; Ahmad Z; Chundriger Q; Ahmed A; Ali N; Abdul-Ghafar J
World J Surg Oncol; 2023 Feb; 21(1):63. PubMed ID: 36843105
[TBL] [Abstract] [Full Text] [Related]
15. Genetic characteristics and treatment outcome in infants with KMT2A germline B-cell precursor acute lymphoblastic leukemia: Results of MLL-Baby protocol.
Popov A; Tsaur G; Permikin Z; Henze G; Verzhbitskaya T; Plekhanova O; Nokhrina E; Valochnik A; Sibiryakov P; Zerkalenkova E; Olshanskaya Y; Gindina T; Movchan L; Shorikov E; Streneva O; Khlebnikova O; Makarova O; Arakaev O; Boichenko E; Kondratchik K; Ponomareva N; Lapotentova E; Aleinikova O; Miakova N; Novichkova G; Karachunskiy A; Fechina L
Pediatr Blood Cancer; 2023 Apr; 70(4):e30204. PubMed ID: 36715125
[TBL] [Abstract] [Full Text] [Related]
16. Primary diffuse large B-cell lymphoma of the breast: A retrospective study of outcomes and insulin resistance.
Zhou W; Yu G; Liu L; Gao Q; Feng L; Wang Y
Saudi Med J; 2023 Jan; 44(1):38-44. PubMed ID: 36634942
[TBL] [Abstract] [Full Text] [Related]
17. Classic Hodgkin lymphoma with marked granulomatous reaction: A clinicopathologic study of 20 cases.
Xu J; Li S; Yin CC; Patel KP; Tang G; Wang W; Miranda RN; Garces S; Tang Z; Lin P; Medeiros LJ
Hum Pathol; 2023 Apr; 134():114-123. PubMed ID: 36584716
[TBL] [Abstract] [Full Text] [Related]
18. Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.
Sworder BJ; Kurtz DM; Alig SK; Frank MJ; Shukla N; Garofalo A; Macaulay CW; Shahrokh Esfahani M; Olsen MN; Hamilton J; Hosoya H; Hamilton M; Spiegel JY; Baird JH; Sugio T; Carleton M; Craig AFM; Younes SF; Sahaf B; Sheybani ND; Schroers-Martin JG; Liu CL; Oak JS; Jin MC; Beygi S; Hüttmann A; Hanoun C; Dührsen U; Westin JR; Khodadoust MS; Natkunam Y; Majzner RG; Mackall CL; Diehn M; Miklos DB; Alizadeh AA
Cancer Cell; 2023 Jan; 41(1):210-225.e5. PubMed ID: 36584673
[TBL] [Abstract] [Full Text] [Related]
19. Primary central nervous system CD20-negative diffuse large B-cell lymphoma: a case report.
Luo S; Huang X; Li Y; Wang J
BMC Neurol; 2022 Dec; 22(1):504. PubMed ID: 36581860
[TBL] [Abstract] [Full Text] [Related]
20. Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial.
Schwab C; Cranston RE; Ryan SL; Butler E; Winterman E; Hawking Z; Bashton M; Enshaei A; Russell LJ; Kingsbury Z; Peden JF; Barretta E; Murray J; Gibson J; Hinchliffe AC; Bain R; Vora A; Bentley DR; Ross MT; Moorman AV; Harrison CJ
Leukemia; 2023 Mar; 37(3):529-538. PubMed ID: 36550215
[TBL] [Abstract] [Full Text] [Related]
[Next]
